Ultimate magazine theme for WordPress.
Browsing Tag

Copd

Copd

Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmona